Biotech investors in Switzerland
Updated 16 Nov 2026
Venture funds
1 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
Table 1. Biotech investors in Switzerland: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Venture Kick | Startup incubator | Schlieren, Switzerland | •••@venturekick.ch | +41 (2••• |
| Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | •••@sosei.com | 877 28••• |
| BioMedPartners | Venture capital firm | Basel, Switzerland | •••@biomedvc.com | +41 61••• |
| Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | •••@fondation-fit.ch | +41 21••• |
| Verve Ventures | Venture capital firm | Zug, Switzerland | •••@verve.vc | |
| Innosuisse | Government investment office | Berne, Switzerland | •••@innosuisse.ch | +41 58••• |
| VI Partners | Venture capital firm | Altendorf, Switzerland | •••@vipartners.ch | +41 41••• |
| HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | •••@hbmhealthcare.com | +41 41••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 26 of the 32 biotech investors in Switzerland have a published email address, 17 a phone number and 32 a website.
- Venture Kick has the most recorded investments, 1,459, 1,342 of them as lead investor.
- 17 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Venture Kick is an investor in 13 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is UniSieve's $9.0M Series A on 8 October 2026.
- Software is the most common sector across their 395 portfolio companies (53%).
- Early stage venture is the most common investment stage, recorded for 29 of them (91%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Switzerland
30 of 32, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | Health care, Biotech | UniSieve, Cotierra, Jaipur Robotics | 13 | 1,459 | 1,342 | 82 | •••@venturekick.ch | +41 (2••• | In the CSV |
| 2 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 3 | BioMedPartners | Venture capital firm | Basel, Switzerland | Biotech, Health care | TOLREMO therapeutics, Topas Therapeutics, Amal Therapeutics | 87 | 29 | 22 | •••@biomedvc.com | +41 61••• | In the CSV | |
| 4 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program, Government investment office | Lausanne, Switzerland | Health care, Biotech | Adaptyv Biosystems, Carewell, Alithea Genomics | 7 | 345 | 329 | 35 | •••@fondation-fit.ch | +41 21••• | In the CSV |
| 5 | Verve Ventures | Venture capital firm | Zug, Switzerland | Health care, Artificial intelligence | Stake, Nuclera | 2 | 275 | 37 | 35 | •••@verve.vc | In the CSV | |
| 6 | Innosuisse | Government investment office | Berne, Switzerland | Health care, Biotech | UniSieve, KEMARO AG, Seprify | 6 | 232 | 184 | 13 | •••@innosuisse.ch | +41 58••• | In the CSV |
| 7 | MassChallenge Switzerland | Startup accelerator | Renens, Switzerland | Biotech, Artificial intelligence | Treeless, Perovskia, SolidWatts | 5 | 227 | 219 | 2 | In the CSV | ||
| 8 | VI Partners | Venture capital firm | Altendorf, Switzerland | Health care, Biotech | L.E.S.S. | 1 | 111 | 26 | 22 | •••@vipartners.ch | +41 41••• | In the CSV |
| 9 | Pureos Bioventures | Venture capital firm | Küsnacht, Switzerland | Biotech, Health care | NovaGo Therapeutics | 1 | 35 | 13 | 6 | In the CSV | ||
| 10 | HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | Biotech, Health care | 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics | 260 | 47 | 90 | •••@hbmhealthcare.com | +41 41••• | ||
| 11 | redalpine | Venture capital firm | Zürich, Switzerland | Artificial intelligence, Fintech | Basecamp Research, Albatross AI | 2 | 188 | 69 | 22 | •••@redalpine.com | +41 44••• | In the CSV |
| 12 | Nextech Invest | Venture capital firm | Zürich, Switzerland | Health care, Biotech | Circle Pharma, Atavistik Bio | 2 | 100 | 31 | 43 | •••@nextechinvest.com | 41 (0)••• | In the CSV |
| 13 | Eclosion SA | Venture capital firm | Geneva, Switzerland | Biotech, Health care | Chord Therapeutics, ID-GENE ecodiagnostics, Geneva Biotech Center | 16 | 9 | 6 | •••@eclosion.com | +91129••• | ||
| 14 | GoBeyond | Angel group | Zürich, Switzerland | Fintech, Hardware | Datamaran, Blumer, VRdirect | 162 | 7 | 16 | •••@gobeyondinvesting.com | +41 44••• | In the CSV | |
| 15 | Swisscom Ventures | Venture capital firm | Zürich, Switzerland | Hardware, Artificial intelligence | SWISSto12 | 1 | 149 | 43 | 45 | In the CSV | ||
| 16 | Business Angels Switzerland (BAS) | Venture capital firm | Zürich, Switzerland | Health care, Biotech | ZYTLYN Technologies, Regenosca, CareerFairy | 100 | 34 | 5 | •••@businessangels.ch | In the CSV | ||
| 17 | FONGIT Innovation Fund | Startup incubator | Geneva, Switzerland | Health care, Biotech | ORamaVR, FluoSphera | 2 | 56 | 54 | 0 | In the CSV | ||
| 18 | StartAngels Network | Angel group | Zürich, Switzerland | Health care, Biotech | Hylomorph, Peripal, Creoptix | 31 | 9 | 4 | •••@startangels.ch | In the CSV | ||
| 19 | Gebert Rüf Stiftung | Entrepreneurship program, Government investment office | Basel, Switzerland | Biotech, Health care | NXI Therapeutics, Hemotune, POLYNEURON | 22 | 11 | 0 | •••@grstiftung.ch | +41061••• | In the CSV | |
| 20 | BaseLaunch | Startup accelerator | Allschwil, Switzerland | Biotech, Health care | NXI Therapeutics, Engimmune Therapeutics, Stromal Therapeutics | 13 | 11 | 0 | •••@baselaunch.ch | In the CSV | ||
| 21 | Roche Venture Fund | Corporate venture arm | Basel, Switzerland | Health care, Biotech | Cour Pharmaceuticals Development | 1 | 121 | 15 | 41 | •••@roche.com | In the CSV | |
| 22 | Founderful | Venture capital firm | Zürich, Switzerland | Hardware, Artificial intelligence | UniSieve, Adaptyv Biosystems, Zuriq | 4 | 95 | 52 | 8 | In the CSV | ||
| 23 | Endeavour Vision | Venture capital firm | Geneva, Switzerland | Biotech, Health care | Kobojo, OncoEthix, Symetis | 68 | 19 | 22 | •••@endeavourvision.com | +41 22••• | In the CSV | |
| 24 | FONGIT | Startup incubator | Geneva, Switzerland | Hardware, Health care | ORamaVR | 1 | 49 | 27 | 0 | •••@fongit.ch | +41 22••• | In the CSV |
| 25 | Kickfund | Venture capital firm | Basel, Switzerland | Health care, Biotech | a-metal, Adiposs, NXI Therapeutics | 49 | 8 | 1 | •••@kickfund.ch | In the CSV | ||
| 26 | BB Biotech Ventures | Venture capital firm | Zürich, Switzerland | Biotech, Health care | Alpex Pharma, Pevion Biotech | 48 | 5 | 13 | •••@bellevue.ch | +41 44••• | ||
| 27 | Wille Finance | Family office, Private equity firm | Zürich, Switzerland | Health care, Biotech | Incepto Medical | 1 | 38 | 5 | 5 | •••@willefinance.com | +41 44••• | In the CSV |
| 28 | Debiopharm Innovation Fund | Venture capital firm | Lausanne, Switzerland | Health care, Biotech | Altis Labs | 1 | 36 | 19 | 9 | •••@debiopharm.com | 418-65••• | In the CSV |
| 29 | Pictet Private Equity Investors S.A. | Investment bank | Geneva, Switzerland | Artificial intelligence, Biotech | Unique AI, Harbinger Health, Red Date Technology | 30 | 4 | 6 | •••@pictet.com | In the CSV | ||
| 30 | TR Invest | Private equity firm | Tafers, Switzerland | Biotech, Health care | Peripal, Creoptix, Credentis | 23 | 2 | 4 | •••@tr-invest.ch | In the CSV |
Table 2. Biotech investors in Switzerland: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 32.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Venture Kick | Schlieren, Switzerland | 13 | 129 | UniSieve, Cotierra, Jaipur Robotics |
| 2 | Foundation for Innovation and Technology (FIT) | Lausanne, Switzerland | 7 | 30 | Adaptyv Biosystems, Carewell, Alithea Genomics |
| 3 | Innosuisse | Berne, Switzerland | 6 | 29 | UniSieve, KEMARO AG, Seprify |
| 4 | MassChallenge Switzerland | Renens, Switzerland | 5 | 35 | Treeless, Perovskia, SolidWatts |
| 5 | Founderful | Zürich, Switzerland | 4 | 21 | UniSieve, Adaptyv Biosystems, Zuriq |
| 6 | redalpine | Zürich, Switzerland | 2 | 30 | Basecamp Research, Albatross AI |
| 7 | Nextech Invest | Zürich, Switzerland | 2 | 5 | Circle Pharma, Atavistik Bio |
| 8 | Novartis Venture Fund | Basel, Switzerland | 2 | 20 | Hepalink, FoRx Therapeutics |
| 9 | Verve Ventures | Zug, Switzerland | 2 | 50 | Stake, Nuclera |
| 10 | FONGIT Innovation Fund | Geneva, Switzerland | 2 | 5 | ORamaVR, FluoSphera |
| 11 | Wille Finance | Zürich, Switzerland | 1 | 9 | Incepto Medical |
| 12 | Debiopharm Innovation Fund | Lausanne, Switzerland | 1 | 6 | Altis Labs |
| 13 | Pureos Bioventures | Küsnacht, Switzerland | 1 | 6 | NovaGo Therapeutics |
| 14 | Swisscom Ventures | Zürich, Switzerland | 1 | 22 | SWISSto12 |
| 15 | Roche Venture Fund | Basel, Switzerland | 1 | 3 | Cour Pharmaceuticals Development |
Table 3. Biotech investors in Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| UniSieve | UniSieve provides molecular separation membrane solutions for cleantech applications. | Energy | Zürich, Switzerland | Series A | $9.0M | 2026-10-08 | $19.7M | Venture Kick, Founderful, Innosuisse | 11 to 50 | 2018 |
| Cotierra | Cotierra develops decentralized biochar systems for regenerative agriculture. | Software | Zürich, Switzerland | Seed | $3.0M | 2026-09-29 | $4.1M | Venture Kick | 11 to 50 | 2023 |
| Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London, United Kingdom | Series C | $140.0M | 2026-09-23 | $219.9M | redalpine | 51 to 100 | 2019 |
| Incepto Medical | Incepto Medical develops artificial intelligence software for medical imaging. | Artificial intelligence | Paris, France | Series B | $16.0M | 2026-09-22 | $49.2M | Wille Finance | 51 to 100 | 2018 |
| Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Toronto, Canada | Series A | $25.0M | 2026-09-17 | $31.0M | Debiopharm Innovation Fund | 11 to 50 | 2019 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Nextech Invest | 11 to 50 | 2012 |
| Jaipur Robotics | Jaipur Robotics develops computer vision and AI solutions for waste-to-energy plants. | Artificial intelligence | Manno, Switzerland | Seed | $5.0M | 2026-09-07 | $6.1M | Venture Kick | 1 to 10 | 2024 |
| xorlab | xorlab uses machine intelligence to stop sophisticated email attacks at first sight. | Artificial intelligence | Zürich, Switzerland | Series A | $5.8M | 2026-09-01 | $16.4M | Venture Kick | 11 to 50 | 2015 |
| NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren, Switzerland | Series B | $29.7M | 2026-08-31 | $39.7M | Pureos Bioventures | 1 to 10 | 2015 |
| Adaptyv Biosystems | Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. | Artificial intelligence | Lausanne, Switzerland | Series A | $40.0M | 2026-08-25 | $50.9M | Venture Kick, Founderful, Foundation for Innovation and Technology (FIT) | 11 to 50 | 2020 |
Table 4. Biotech investors in Switzerland: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 211 | 53% |
| Health care | 150 | 38% |
| Biotech | 132 | 33% |
| Artificial intelligence | 75 | 19% |
| Hardware | 72 | 18% |
| Fintech | 38 | 10% |
| Energy | 19 | 5% |
| Commerce | 15 | 4% |
| Cybersecurity | 12 | 3% |
| Education | 10 | 3% |
Table 5. Biotech investors in Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 29 | 91% |
| Seed investors | 18 | 56% |
| Late stage investors | 17 | 53% |
| Venture investors | 12 | 38% |
| Convertible note investors | 6 | 19% |
| Private equity investors | 6 | 19% |
| Grant makers | 5 | 16% |
| Post IPO investors | 5 | 16% |
Table 6. Biotech investors in Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Biotech investors in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 2 | 6% |
| 2010s | 8 | 26% |
| 2000s | 13 | 42% |
| 1990s | 7 | 23% |
| 1800s | 1 | 3% |
Table 8. Biotech investors in Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Switzerland. On 16 November 2026 that is 32 investors.
- 26 rows carry an email address and 17 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 32 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Switzerland are on the list?
- 32, in the file dated 16 November 2026. 17 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 26 of the 32 carry an email address in the download and 17 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 32 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 32 rows, 26 firm email addresses and 17 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 20 of the 26 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.